Grant: Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
McGill University
$0.00
Emerging Team in Chemical and Structural Biology of Cystic Fibrosis
EF 2008-09
Résumé
Most cystic fibrosis (CF) is caused by mutations that cause partial misfolding and retention of the cystic fibrosis transmembrane conductance regulator (CFTR) in the endoplasmic reticulum (ER). Despite great strides in basic CF research, there remains no cure. We will determine the mechanisms responsible for CFTR retention in the ER, identify potential targets for small molecules that rescue trafficking of the major disease-causing mutant, establish functional assays and use them to evaluate molecular targets and correctors, and develop new research tools and therapeutic strategies that may be applicable to protein misfolding diseases generally. The work will be carried out by investigators with broad expertise in chemical and structural biology, protein folding, live cell imaging of protein dynamics, CF pathophysiology, and drug discovery.
Programme
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
174387
Name
Hanrahan John W
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients
Projecttitle
Emerging Team in Chemical and Structural Biology of Cystic Fibrosis
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$0
Cihrequipment2
$0
Programname2
Emerging Team Grant: From Genes to Proteins, Cells, Tissues and Patients - LOI
Keyworddelim
Cystic Fibrosis; Protein Folding; Protein Structure And Function; Protein Trafficking Diseases; Respiratory Health; Therapeutics
Abstract
Most cystic fibrosis (CF) is caused by mutations that cause partial misfolding and retention of the cystic fibrosis transmembrane conductance regulator (CFTR) in the endoplasmic reticulum (ER). Despite great strides in basic CF research, there remains no cure. We will determine the mechanisms responsible for CFTR retention in the ER, identify potential targets for small molecules that rescue trafficking of the major disease-causing mutant, establish functional assays and use them to evaluate molecular targets and correctors, and develop new research tools and therapeutic strategies that may be applicable to protein misfolding diseases generally. The work will be carried out by investigators with broad expertise in chemical and structural biology, protein folding, live cell imaging of protein dynamics, CF pathophysiology, and drug discovery.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hanrahan, John W
Approvedterm
1 an 0 mois